Cargando…
Reply to Dr. Witjes regarding universal tumor genomic sequencing as a prescreen for germline genetic testing in patients diagnosed with ovarian cancer
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683680/ https://www.ncbi.nlm.nih.gov/pubmed/34977314 http://dx.doi.org/10.1016/j.gore.2021.100843 |
_version_ | 1784617468906438656 |
---|---|
author | Lin, Jenny Frey, Melissa K. |
author_facet | Lin, Jenny Frey, Melissa K. |
author_sort | Lin, Jenny |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8683680 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-86836802021-12-30 Reply to Dr. Witjes regarding universal tumor genomic sequencing as a prescreen for germline genetic testing in patients diagnosed with ovarian cancer Lin, Jenny Frey, Melissa K. Gynecol Oncol Rep Correspondence Elsevier 2021-07-29 /pmc/articles/PMC8683680/ /pubmed/34977314 http://dx.doi.org/10.1016/j.gore.2021.100843 Text en © 2021 Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Correspondence Lin, Jenny Frey, Melissa K. Reply to Dr. Witjes regarding universal tumor genomic sequencing as a prescreen for germline genetic testing in patients diagnosed with ovarian cancer |
title | Reply to Dr. Witjes regarding universal tumor genomic sequencing as a prescreen for germline genetic testing in patients diagnosed with ovarian cancer |
title_full | Reply to Dr. Witjes regarding universal tumor genomic sequencing as a prescreen for germline genetic testing in patients diagnosed with ovarian cancer |
title_fullStr | Reply to Dr. Witjes regarding universal tumor genomic sequencing as a prescreen for germline genetic testing in patients diagnosed with ovarian cancer |
title_full_unstemmed | Reply to Dr. Witjes regarding universal tumor genomic sequencing as a prescreen for germline genetic testing in patients diagnosed with ovarian cancer |
title_short | Reply to Dr. Witjes regarding universal tumor genomic sequencing as a prescreen for germline genetic testing in patients diagnosed with ovarian cancer |
title_sort | reply to dr. witjes regarding universal tumor genomic sequencing as a prescreen for germline genetic testing in patients diagnosed with ovarian cancer |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683680/ https://www.ncbi.nlm.nih.gov/pubmed/34977314 http://dx.doi.org/10.1016/j.gore.2021.100843 |
work_keys_str_mv | AT linjenny replytodrwitjesregardinguniversaltumorgenomicsequencingasaprescreenforgermlinegenetictestinginpatientsdiagnosedwithovariancancer AT freymelissak replytodrwitjesregardinguniversaltumorgenomicsequencingasaprescreenforgermlinegenetictestinginpatientsdiagnosedwithovariancancer |